What is the official website of BENU Slovensko ?

The official website of BENU Slovensko is https://benukariera.sk/.

What is BENU Slovensko's cybersecurity risk score?

BENU Slovensko has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has BENU Slovensko experienced?

According to Rankiteo, BENU Slovensko currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has BENU Slovensko been affected by any supply chain cyber incidents ?

According to Rankiteo, BENU Slovensko has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does BENU Slovensko have SOC 2 Type 1 certification ?

According to Rankiteo, BENU Slovensko is not certified under SOC 2 Type 1.

Does BENU Slovensko have SOC 2 Type 2 certification ?

According to Rankiteo, BENU Slovensko does not hold a SOC 2 Type 2 certification.

Does BENU Slovensko comply with GDPR ?

According to Rankiteo, BENU Slovensko is not listed as GDPR compliant.

Does BENU Slovensko have PCI DSS certification ?

According to Rankiteo, BENU Slovensko does not currently maintain PCI DSS compliance.

Does BENU Slovensko comply with HIPAA ?

According to Rankiteo, BENU Slovensko is not compliant with HIPAA regulations.

Does BENU Slovensko have ISO 27001 certification ?

According to Rankiteo,BENU Slovensko is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does BENU Slovensko operate in ?

BENU Slovensko operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does BENU Slovensko have ?

BENU Slovensko employs approximately 152 people worldwide.

Does BENU Slovensko own any subsidiaries ?

BENU Slovensko presently has no subsidiaries across any sectors.

How many LinkedIn followers does BENU Slovensko have ?

BENU Slovensko's official LinkedIn profile has approximately 1,458 followers.

What is the NAICS classification code for BENU Slovensko ?

BENU Slovensko is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does BENU Slovensko have a Crunchbase profile ?

No, BENU Slovensko does not have a profile on Crunchbase.

Does BENU Slovensko have a LinkedIn profile ?

Yes, BENU Slovensko maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/benu-slovensko.

How many cybersecurity incidents has BENU Slovensko experienced ?

As of August 28, 2026, Rankiteo reports that BENU Slovensko has not experienced any cybersecurity incidents.

How many peer or competitor companies does BENU Slovensko have ?

BENU Slovensko has an estimated 5,746 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BENU Slovensko

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

BENU Slovensko Vendor Cyber Rating & Cyber Score

benukariera.sk

Add Your Compliance Badge

Sieť lekárni BENU je najväčšou lekárenskou sieťou v kontinentálnej Európe a pod značkou BENU je otvorených viac ako 1 400 lekární. Na Slovensku pôsobí spoločnosť BENU od roku 2016. Máme viac ako 140 kamenných lekární a internetovú lekáreň www.benulekaren.sk. Značka BENU symbolizuje kvalitu vo všetkých oblastiach, smerom k zákazníkom a pacientom, obchodným partnerom a inštitúciám, ako aj k zamestnancom. Charakterizuje nás mytologický vták BENU, ktorý bol už odpradávna symbolom života a dobrého zdravia. Naši lekárnici sú profesionáli, vždy vám pomôžu nájsť čo najlepšie riešenie. Naše odborné služby a individuálny prístup sú pre nás samozrejmosťou. Patríme pod spoločnosť PHOENIX Zdravotnícke zásobovanie, a. s., ktorá podporuje aj

BENU Slovensko A.I CyberSecurity Scoring

Scoring History

BENU Slovensko

BENU Slovensko CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

BENU Slovensko Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BENU Slovensko

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BENU Slovensko in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for BENU Slovensko in 2026.

Incident Types BENU Slovensko vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BENU Slovensko in 2026.

Incident History - BENU Slovensko (X = Date, Y = Severity)

Loading…

SUBSIDIARY

BENU Slovensko Subsidiaries

BENU Slovensko

Pharmaceutical Manufacturing

Website: https://benukariera.sk/

Company Size: 1,001-5,000 employees

PHOENIX group - Integrated Healthcare ProviderWholesale

BENU FarmaciaPharmaceutical Manufacturing

Gruppo ComifarTransportation, Logistics, Supply Chain and Storage

NomecoTransportation, Logistics, Supply Chain and Storage

Help Net FarmaPharmaceutical Manufacturing

PHOENIX Pharma BulgariaPharmaceutical Manufacturing

FarmeximWholesale Drugs and Sundries

PHX IrelandPharmaceutical Manufacturing

OCP PortugalWholesale

Apotek 1Pharmaceutical Manufacturing

PHOENIX Pharmahandel GmbH & Co KGWholesale

PHOENIX Pharma ItaliaWholesale

BENU BelgiumPharmaceutical Manufacturing

PHOENIX FarmacijaPharmaceutical Manufacturing

Tamro FinlandWholesale

Tamro BalticsPharmaceutical Manufacturing

Tamro SwedenPharmaceutical Manufacturing

SmilaHospitals and Health Care

EL PHARMA – PHOENIX group Representation ServicesHealth and Human Services

Pharmacies BENU SAPharmaceutical Manufacturing

PHOENIX BelgiumHospitals and Health Care

PHOENIX Pharma Switzerland AGHealth and Human Services

PHOENIX Medical Supplies LtdPharmaceutical Manufacturing

Kemofarmacija d.d.Wholesale

SOFIADISWholesale

PHOENIX Zdravotnícke zásobovanie, a.s.Wholesale

Loading…

BENU Slovensko Similar Companies

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Loading…

NEWS

BENU Slovensko CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-81934

SUMMARY

Redis contains a use-after-free vulnerability in the 'tlsProcessPendingData()' function, which handles the TLS pending-data list if Redis is configured with TLS support. A remote, unauthenticated attacker may be able to execute arbitrary commands with the privileges of the Redis server. Fixed in Redis 8.2.9, 8.4.6, 8.6.6, 8.8.2, and 8.10.1.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-81931

SUMMARY

Unrestricted Upload of File with Dangerous Type in the product photo upload in Roskus Prospero Flow CRM before 5.16.0 allows an authenticated user holding the create product permission (routine Seller role) to execute arbitrary JavaScript in the application origin. The photo validation rule classifies the file only by its content (magic bytes) and rejects only a fixed list of PHP extensions, while ProductSaveController::save() names the stored file using the client-supplied extension and copies it into the public web root. A file that begins with an image header and carries an HTML extension passes validation, is stored under public/asset/upload/product/, and is served with a text/html content type, turning the upload into first-party stored script execution.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: )

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-81893

SUMMARY

A flaw was found in gdk-pixbuf. When loading a specially crafted JPEG image containing chunked ICC profile markers, an error during ICC profile parsing can leave stale size metadata after the profile buffer is freed. A subsequent allocation in the same decode can cause an out-of-bounds write, potentially crashing the application. To exploit this flaw, an application using gdk-pixbuf must process the malicious JPEG image. Affected version >= 2.26.4

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 4.7)

cvss3

Base Score: 4.7

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

REFERENCES

CVE-2026-81838

SUMMARY

A relative path traversal issue in the zip extraction functionality in AWS diagram-as-code (awsdac) in versions 0.10 through 0.23 can allow a third party to write arbitrary files to the local filesystem via crafted zip entry names containing path traversal sequences. This could allow the third party to perform inappropriate actions in the diagram bundle. To remediate this issue, users should upgrade to the version 0.24 or later.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:H

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

1.8

REFERENCES

CVE-2026-81834

SUMMARY

A weakness has been identified in RooCodeInc Roo-Code up to 3.51.1. Affected by this issue is the function ExecaTerminalProcess of the component README File Handler. Executing a manipulation can lead to code injection. The attack can be executed remotely. The exploit has been made available to the public and could be used for attacks. Multiple isses were reported to the vendor beforehand. They explain, that "they all apply to Roo Code, a project we no longer support - the repository was archived a while ago, and we don't encourage anyone to use it." This vulnerability only affects products that are no longer supported by the maintainer.

Published

Date2026-08-27

Updated

Date2026-08-27

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…